Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76390506 | 7639050 | 6 | F | 201007 | 20160912 | 20101025 | 20160914 | EXP | PHHY2010BG70159 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160915 | MD | BG | BG |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76390506 | 7639050 | 1 | PS | LESCOL XL | FLUVASTATIN SODIUM | 1 | Oral | 80 MG, QD | Y | 21192 | 80 | MG | SLOW RELEASE TABLET | QD | |||||
| 76390506 | 7639050 | 2 | C | INVEGA | PALIPERIDONE | 1 | Unknown | UNK MG, UNK | 0 | ||||||||||
| 76390506 | 7639050 | 3 | C | ZOPICLONE | ZOPICLONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 76390506 | 7639050 | 4 | C | XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 76390506 | 7639050 | 5 | C | PANCEF//CEFIXIME | 2 | Unknown | 500 OT, QD | U | 0 | QD | |||||||||
| 76390506 | 7639050 | 6 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 76390506 | 7639050 | 7 | C | OMNIC | TAMSULOSIN HYDROCHLORIDE | 1 | Unknown | 1 DF, QD | U | 0 | 1 | DF | QD | ||||||
| 76390506 | 7639050 | 8 | C | DEGAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1 DF, UNK | U | 0 | 1 | DF | AMPOULE |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 76390506 | 7639050 | 1 | Dyslipidaemia |
| 76390506 | 7639050 | 2 | Schizophrenia |
| 76390506 | 7639050 | 3 | Product used for unknown indication |
| 76390506 | 7639050 | 4 | Product used for unknown indication |
| 76390506 | 7639050 | 5 | Product used for unknown indication |
| 76390506 | 7639050 | 6 | Product used for unknown indication |
| 76390506 | 7639050 | 7 | Product used for unknown indication |
| 76390506 | 7639050 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 76390506 | 7639050 | LT |
| 76390506 | 7639050 | HO |
| 76390506 | 7639050 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 76390506 | 7639050 | Abnormal behaviour | |
| 76390506 | 7639050 | Alanine aminotransferase increased | |
| 76390506 | 7639050 | Ammonia increased | |
| 76390506 | 7639050 | Amylase increased | |
| 76390506 | 7639050 | Anxiety | |
| 76390506 | 7639050 | Aspartate aminotransferase increased | |
| 76390506 | 7639050 | Blood albumin decreased | |
| 76390506 | 7639050 | Blood alkaline phosphatase increased | |
| 76390506 | 7639050 | Blood calcium decreased | |
| 76390506 | 7639050 | Blood cholinesterase increased | |
| 76390506 | 7639050 | Blood creatine phosphokinase MB | |
| 76390506 | 7639050 | Blood creatine phosphokinase increased | |
| 76390506 | 7639050 | Blood fibrinogen decreased | |
| 76390506 | 7639050 | Blood iron decreased | |
| 76390506 | 7639050 | Blood potassium decreased | |
| 76390506 | 7639050 | Blood sodium decreased | |
| 76390506 | 7639050 | Blood triglycerides increased | |
| 76390506 | 7639050 | Blood urea increased | |
| 76390506 | 7639050 | Blood uric acid increased | |
| 76390506 | 7639050 | Brain oedema | |
| 76390506 | 7639050 | Chromaturia | |
| 76390506 | 7639050 | Coma | |
| 76390506 | 7639050 | Decubitus ulcer | |
| 76390506 | 7639050 | Deep vein thrombosis | |
| 76390506 | 7639050 | Dementia | |
| 76390506 | 7639050 | Dry mouth | |
| 76390506 | 7639050 | Dysarthria | |
| 76390506 | 7639050 | Dyslipidaemia | |
| 76390506 | 7639050 | Encephalopathy | |
| 76390506 | 7639050 | Epidermolysis | |
| 76390506 | 7639050 | Epistaxis | |
| 76390506 | 7639050 | Faeces discoloured | |
| 76390506 | 7639050 | Fibrin D dimer increased | |
| 76390506 | 7639050 | Gamma-glutamyltransferase | |
| 76390506 | 7639050 | Gamma-glutamyltransferase increased | |
| 76390506 | 7639050 | General physical health deterioration | |
| 76390506 | 7639050 | Haematemesis | |
| 76390506 | 7639050 | Haematocrit decreased | |
| 76390506 | 7639050 | Haemoglobin decreased | |
| 76390506 | 7639050 | High density lipoprotein decreased | |
| 76390506 | 7639050 | Hypersensitivity | |
| 76390506 | 7639050 | Hypertension | |
| 76390506 | 7639050 | Hypoaesthesia | |
| 76390506 | 7639050 | Insomnia | |
| 76390506 | 7639050 | International normalised ratio increased | |
| 76390506 | 7639050 | Lactate dehydrogenase urine increased | |
| 76390506 | 7639050 | Lymphocyte count | |
| 76390506 | 7639050 | Muscle injury | |
| 76390506 | 7639050 | Muscular weakness | |
| 76390506 | 7639050 | Myoglobin blood increased | |
| 76390506 | 7639050 | Nausea | |
| 76390506 | 7639050 | Oedema peripheral | |
| 76390506 | 7639050 | Oesophageal disorder | |
| 76390506 | 7639050 | Pain | |
| 76390506 | 7639050 | Pallor | |
| 76390506 | 7639050 | Paraesthesia | |
| 76390506 | 7639050 | Protein total decreased | |
| 76390506 | 7639050 | Red blood cell count decreased | |
| 76390506 | 7639050 | Red blood cell sedimentation rate increased | |
| 76390506 | 7639050 | Rhabdomyolysis | |
| 76390506 | 7639050 | Somnolence | |
| 76390506 | 7639050 | Syncope | |
| 76390506 | 7639050 | Thirst | |
| 76390506 | 7639050 | Tongue biting | |
| 76390506 | 7639050 | Urinary incontinence | |
| 76390506 | 7639050 | Vomiting | |
| 76390506 | 7639050 | White blood cell disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 76390506 | 7639050 | 1 | 201010 | 0 |